General Information of MET (ID: META00582)
Name SM(d18:1/16:0)
Synonyms   Click to Show/Hide Synonyms of This Metabolite
(2S,3R,4E)-2-(Palmitoylamino)-3-hydroxyoctadec-4-en-1-yl 2-(trimethylazaniumyl)ethyl phosphate; (2S,3R,4E)-2-(Palmitoylamino)-3-hydroxyoctadec-4-en-1-yl 2-(trimethylazaniumyl)ethyl phosphoric acid; (2S,3R,4E)-3-Hydroxy-2-(palmitoylamino)octadec-4-en-1-yl 2-(trimethylazaniumyl)ethyl phosphate; (2S,3R,4E)-3-Hydroxy-2-(palmitoylamino)octadec-4-en-1-yl 2-(trimethylazaniumyl)ethyl phosphoric acid; C16 Sphingomyelin; C16-Sphingomyelin; Hexadecanoyl sphingomyelin; N-(Hexadecanoyl)-sphing-4-enine-1-phosphocholine; N-Hexadecanoylsphing-4-enine-1-phosphocholine; N-Hexadecanoylsphingomyelin; N-PSPC; N-Palmitoyl-D-erythro-sphingosylphosphorylcholine; N-Palmitoyl-D-erythrosphingosylphosphorylcholine; N-Palmitoyl-D-sphingomyelin; N-Palmitoylsphing-4-enine-1-phosphocholine; N-Palmitoylsphingomyelin; N-Palmitoylsphingosine-1-phosphocholine; N-Palmitoylsphingosine-phosphorylcholine; N-Palmitoylsphingosylphosphorylcholine; Palmitoyl sphingomyelin; Palmitoyl sphingomyelin (D18:1/16:0); Palmitoylsphingomyelin; SM(18:1/16:0); SM(D18:1/16:0); Sphingomyelin (D18:1/16:0); Sphingomyelin (d18:1 C16:0); Sphingomyelin (dC18:1/C16:0); Sphingomyelin 16:0; Sphingomyelin D18:1/16:0; Sphingomyelin(D18:1/16:0)
Source Aliphatic acyclic compounds
Structure Type   Phosphosphingolipids  (Click to Show/Hide the Complete Structure Type Hierarchy)
Lipids and lipid-like molecules
Sphingolipids
Phosphosphingolipids
PubChem CID
9939941
HMDB ID
HMDB0010169
Formula
C39H79N2O6P
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=9939941"></iframe>
3D MOL is unavailable 2D MOL
  Click to Show/Hide the Molecular/Functional Data (External Links/Property/Function) of This Metabolite
ChEBI ID
78646
FooDB ID
FDB027352
ChemSpider ID
8115562
Physicochemical Properties Molecular Weight 703 Topological Polar Surface Area 108
XlogP 12.3 Complexity 796
Heavy Atom Count 48 Rotatable Bond Count 36
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 6
Function
Sphingomyelin (d18:1/16:0) or SM(d18:1/16:0) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. SM(d18:1/16:0) consists of a sphingosine backbone and a palmitic acid chain. In humans, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SM has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition, it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2, an enzyme that breaks down sphingomyelin into ceramide, has been found to localize exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme sphingomyelinase, which causes the accumulation of sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase.
Regulatory Network
Full List of Protein(s) Regulating This Metabolite
      Hydrolases (EC 3)
            Sulfatase sulf-1 (SULF1) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [1]
                      Introduced Variation Knockdown (shRNA) of SULF1
                      Induced Change SM(d18:1/16:0) concentration: increase (FC = 1.52 - 1.62)
                      Summary Introduced Variation         Induced Change 
                      Disease Status Ovarian cancer [ICD-11: 2C73]
                      Details It is reported that knockdown of SULF1 leads to the increase of SM(d18:1/16:0) levels compared with control group.
References
1 Erratum to: Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer. Cancer Metab. 2014 Nov 4;2:24.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.